MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$5.83 USD
+0.18 (3.19%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $5.83 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 82 | 66 | 87 | 96 | 69 |
Receivables | 54 | 44 | 41 | 45 | 32 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 21 | 13 | 11 | 10 | 9 |
Other Current Assets | 7 | 11 | 9 | 9 | 13 |
Total Current Assets | 164 | 134 | 149 | 161 | 123 |
Net Property & Equipment | 7 | 8 | 9 | 11 | 12 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 41 | 0 | 0 | 0 | 0 |
Intangibles | 25 | 26 | 25 | 26 | 28 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 239 | 171 | 188 | 202 | 167 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 9 | 9 | 7 | 9 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 4 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 32 | 33 | 33 | 49 | 53 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 2 | 2 | 1 | 1 |
Total Current Liabilities | 46 | 44 | 42 | 59 | 67 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 48 | 49 | 48 | 48 | 62 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 5 | 5 | 4 | 4 |
Minority Interest (Liabilities) | 0 | 92 | 92 | 92 | 0 |
Total Liabilities | 96 | 189 | 188 | 202 | 133 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 276 | 174 | 166 | 159 | 147 |
Retained Earnings | -134 | -192 | -162 | -151 | -102 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 4 | 7 | 11 |
Total Shareholder's Equity | 143 | -18 | 0 | 0 | 34 |
Total Liabilities & Shareholder's Equity | 239 | 171 | 188 | 202 | 167 |
Total Common Equity | 143 | -18 | 0 | 0 | 34 |
Shares Outstanding | 146.20 | 113.60 | 112.10 | 111.00 | 110.70 |
Book Value Per Share | 0.98 | -0.16 | 0.00 | 0.00 | 0.31 |
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 69 | 48 | 82 | 81 | 69 |
Receivables | 53 | 57 | 54 | 49 | 49 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 25 | 24 | 21 | 19 | 17 |
Other Current Assets | 7 | 9 | 7 | 5 | 7 |
Total Current Assets | 154 | 139 | 164 | 155 | 141 |
Net Property & Equipment | 7 | 7 | 7 | 7 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 33 | 39 | 41 | 0 | 0 |
Intangibles | 31 | 32 | 25 | 25 | 25 |
Deposits & Other Assets | 1 | 1 | 0 | 0 | 0 |
Total Assets | 230 | 222 | 239 | 189 | 176 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 8 | 10 | 9 | 9 | 8 |
Current Portion Long-Term Debt | 1 | 1 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 27 | 27 | 32 | 33 | 34 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 4 | 4 | 5 | 2 | 2 |
Total Current Liabilities | 40 | 42 | 46 | 44 | 44 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 18 | 18 | 48 | 49 | 49 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 2 | 3 | 3 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 92 | 92 |
Total Liabilities | 62 | 66 | 96 | 188 | 189 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 275 | 280 | 276 | 188 | 183 |
Retained Earnings | -107 | -124 | -134 | -187 | -196 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 168 | 156 | 143 | 1 | -13 |
Total Liabilities & Shareholder's Equity | 230 | 222 | 239 | 189 | 176 |
Total Common Equity | 168 | 156 | 143 | 1 | -13 |
Shares Outstanding | 146.80 | 147.60 | 146.20 | 116.30 | 116.10 |
Book Value Per Share | 1.14 | 1.06 | 0.98 | 0.01 | -0.11 |